Stakeholder Perspectives on Trustworthy AI for Parkinson Disease Management Using a Cocreation Approach: Qualitative Exploratory Study (Preprint)
Authors:
- Beatriz AlvesBABeatriz Alves
- Ghada AlhusseinGAGhada Alhussein
- Sara RiggareSRSara Riggare
- Therese Scott DuncanTDTherese Scott Duncan
- Ali SaadASAli Saad
- David M LyreskogDLDavid M Lyreskog
- Christos ChatzichristosChristos Chatzichristos
- Ioannis GerasimouIGIoannis Gerasimou
- Stelios HadjidimitriouSHStelios Hadjidimitriou
- Leontios J HadjileontiadisLHLeontios J Hadjileontiadis
- Sofia B DiasSDSofia B Dias
Preprint
- 10 March 2025
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Parkinson disease (PD) is the fastest-growing neurodegenerative disorder in the world, with prevalence expected to exceed 12 million by 2040, which poses significant health care and societal challenges. Artificial intelligence (AI) systems and wearable sensors hold potential for PD diagnosis, personalized symptom monitoring, and progression prediction. Nonetheless, ethical AI adoption requires several core principles, including user trust, transparency, fairness, and human oversight. OBJECTIVE This study aims to explore and synthesize the perspectives of diverse stakeholders, such as individuals living with PD, health care professionals, AI experts, and bioethicists. The aim was to guide the development of AI-driven digital health solutions, emphasizing transparency, data security, fairness, and bias mitigation while ensuring robust human oversight. These efforts are part of the broader Artificial Intelligence-Based Parkinson’s Disease Risk Assessment and Prognosis (AI-PROGNOSIS) European project, dedicated to advancing ethical and effective AI applications in PD diagnosis and management. METHODS An exploratory qualitative approach, based on 2 datasets constructed from cocreation workshops, engaged key stakeholders with diverse expertise to gather insights, ensuring a broad range of perspectives and enriching the thematic analysis. A total of 24 participants participated in the cocreation workshops, including 11 (46%) people with PD, 6 (25%) health care professionals, 3 (13%) AI technical experts, 1 (4%) bioethics expert, and 3 (13%) facilitators. Using a semistructured guide, key aspects of the discussion centered on trust, fairness, explainability, autonomy, and the psychological impact of AI in PD care. RESULTS Thematic analysis of the cocreation workshop transcripts identified 5 key main themes, each explored through various corresponding subthemes. AI trust and security (theme 1) was highlighted, focusing on data safety and the accuracy and reliability of the AI systems. AI transparency and education (theme 2) emphasized the need for educational initiatives and the importance of transparency and explainability of AI technologies. AI bias (theme 3) was identified as a critical theme, addressing issues of bias and fairness and ensuring equitable access to AI-driven health care solutions. Human oversight (theme 4) stressed the significance of AI-human collaboration and the essential role of human review in AI processes. Finally, AI’s psychological impact (theme 5) examined the emotional impact of AI on patients and how AI is perceived in the context of PD care. CONCLUSIONS Our findings underline the importance of implementing robust security measures, developing transparent and explainable AI models, reinforcing bias mitigation and reduction strategies and equitable access to treatment, integrating human oversight, and considering the psychological impact of AI-assisted health care. These insights provide actionable guidance for developing trustworthy and effective AI-driven digital PD diagnosis and management solutions. CLINICALTRIALKeywords
All Related Versions
- Published version: Journal of Medical Internet Research, 27, e73710.
This publication has 51 references indexed in Scilit:
- Houston, We Have AI Problem! Quality Issues with Neuroimaging‐Based Artificial Intelligence in Parkinson's Disease: A Systematic ReviewMovement Disorders, 2024
- Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness StudyDrugs - Real World Outcomes, 2024
- Attitudes Toward the Adoption of Remote Patient Monitoring and Artificial Intelligence in Parkinson’s Disease Management: Perspectives of Patients and NeurologistsThe Patient - Patient-Centered Outcomes Research, 2024
- Institutionalised distrust and human oversight of artificial intelligence: towards a democratic design of AI governance under the European Union AI ActAI & SOCIETY, 2023
- Trust and trustworthiness in AI ethicsAI and Ethics, 2022
- Six Action Steps to Address Global Disparities in Parkinson DiseaseJAMA Neurology, 2022
- Developing ambient assisted living technologies exploiting potential of user-centred co-creation and agile methodology: the CAPTAIN project experienceJournal of Ambient Intelligence and Humanized Computing, 2022
- Predicting motor, cognitive & functional impairment in Parkinson'sAnnals of Clinical and Translational Neurology, 2019
- Development of the Integrated Parkinson’s Care Network (IPCN): using co-design to plan collaborative care for people with Parkinson’s diseaseQuality of Life Research, 2019
- Technology in Parkinson's disease: Challenges and opportunitiesMovement Disorders, 2016